Pentamidine Isethionate Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Mar 23, 2026 · last update Mar 23, 2026
Manufacturers: XGen Pharmaceuticals DJB, Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2) | XGen Pharmaceuticals DJB, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Mar 23, 2026 Updated Mar 23, 2026 Discontinued Mar 23, 2026 |